MedPath
HSA Approval

HYDRINE CAPSULES 500 mg

SIN11083P

HYDRINE CAPSULES 500 mg

HYDRINE CAPSULES 500 mg

August 25, 1999

SHOEI UNIVERSAL CORPORATION PTE LTD

SHOEI UNIVERSAL CORPORATION PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantSHOEI UNIVERSAL CORPORATION PTE LTD
Licence HolderSHOEI UNIVERSAL CORPORATION PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

CAPSULE

ORAL

Medical Information

L01XX05

hydroxycarbamide

Manufacturer Information

SHOEI UNIVERSAL CORPORATION PTE LTD

KOREA UNITED PHARM. INC.

Active Ingredients

HYDROXYUREA

500 mg

Hydroxyurea

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

HYDRINE CAPSULES 500 mg - HSA Approval | MedPath